1. A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer

   • Charlie Gourley
   • James Cassidy
   • Duncan Jodrell

   Original Article 07 November 2003 Pages: 95 - 101

   

2. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

   • Ann E. Bolton
   • Bin Peng
   • Michael Seiberling

   Original Article 07 November 2003 Pages: 102 - 106

   

3. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase

   • Michael C. Nivens
   • Takita Felder
   • H. Trent Spencer

   Original Article 07 November 2003 Pages: 107 - 115

   

4. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions

   • Johnathan C. Maher
   • Awtar Krishan
   • Theodore J. Lampidis

   Original Article 07 November 2003 Pages: 116 - 122

   

5. The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy

   • James Carmichael
   • Adrian L. Harris

   Original Article 22 November 2003 Pages: 123 - 128

6. Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

   • Kiyoshi Mori
   • Yukari Kamiyama
   • Keigo Tominaga

   Original Article 07 November 2003 Pages: 129 - 132

7. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice

   • Kristan A. Keyes
   • Larry Mann
   • Beverly A. Teicher

   Original Article 31 October 2003 Pages: 133 - 140

   

8. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats

   • Shri N. Giri
   • Mohammed Ali Al-Bayati
   • Solomon B. Margolin

   Original Article 15 October 2003 Pages: 141 - 150

   

9. Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma

   • Hiroyoshi Oguri
   • Nagamasa Maeda
   • Takao Fukaya

   Original Article 12 November 2003 Pages: 151 - 154

10. Differences in the longevity of topo IIα and topo IIβ drug-stabilized cleavable complexes and the relationship to drug sensitivity

    • Fiona Errington
    • Elaine Willmore
    • Caroline A. Austin

    Original Article 23 September 2003 Pages: 155 - 162

    

11. Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress

    • María S. Molinuevo
    • Daniel A. Barrio
    • Susana B. Etcheverry

    Original Article 09 October 2003 Pages: 163 - 172

    

12. The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice

    • E. Marleen Kemper
    • Cindy Cleypool
    • Olaf van Tellingen

    Original Article 07 November 2003 Pages: 173 - 178

    

13. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells

    • Anna Bielak-Żmijewska
    • Katarzyna Piwocka
    • Ewa Sikora

    Original Article 03 October 2003 Pages: 179 - 185

    

14. In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells

    • Rita Nahta
    • Francisco J. Esteva

    Short Communication 07 November 2003 Pages: 186 - 190